Menu

V

Vaccitech

Verified

Visit Website Connect with Founders

Vaccitech is creating novel vaccines that elicit strong responses from helper and cytotoxic T-cells. Healthcare Medical Research

About Vaccitech

Vaccitech builds in the healthcare category and is tracked by 100Xfounder for operating momentum, talent growth, and market execution.

What they do: Vaccitech is creating novel vaccines that elicit strong responses from helper and cytotoxic T-cells. Healthcare Medical Research

Funding context: Sequoia, Post-IPO, $290M valuation

Recent milestones:

Vaccitech appears in the 100Xfounder startup directory import feed.

Why it Matters

Vaccitech matters because vaccitech is creating novel vaccines that elicit strong responses from helper and cytotoxic T-cells. Healthcare Medical Research

Funding Snapshot

Total Funding: $290.00MLast Round: IPO Sequoia, Post-IPO, $290M valuationAll Rounds: 1

IPO | Sequoia, Post-IPO, $290M valuation

Hiring Roles

This company is actively hiring.

Open Roles

Meet the Founders

Vaccitech Team

Vaccitech Team

Founder & CEO

Tech Stack

PythonGCPBigQueryReact

Last updated: April 17, 2026

Vaccitech intelligence brief

This profile combines core company context with linked founder, funding, and newsroom routes so readers can evaluate business momentum without switching across multiple tools. Use it as a baseline for comparing peers in the same industry and stage.

For deeper validation, pair this page with founder profile, company news coverage, and stage-based funding hubs to contextualize updates against wider market movement.

Related Companies

Alternatives in Healthcare with comparable market signals.

T

Thatch Team

View Company Compare Alternatives

T

Tempo Team

View Company Compare Alternatives

N

Neuralink Team

View Company Compare Alternatives

C

Cedar Team

View Company Compare Alternatives

SH

SWORD Health Team

View Company Compare Alternatives

SM

Scipher Medicine

Scipher Medicine Team

View Company Compare Alternatives

C

Calibrate Team

View Company Compare Alternatives

F

Forward Team

View Company Compare Alternatives

Discover Now

Newsroom and topic pages connected to Vaccitech.

Company News Hub Topic Hubs Funding News

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Company profile→Company news hub→Founder profile→United Kingdom startup directory→United Kingdom startup news→Healthcare hub→Healthcare startup list→Ipo startups→Ipo startup list→Ipo newsroom→

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

Contact Editorial Get Featured

FAQs About Vaccitech

Common questions people ask about this profile.

What is Vaccitech?

Vaccitech is creating novel vaccines that elicit strong responses from helper and cytotoxic T-cells. Healthcare Medical Research

Who founded Vaccitech?

Vaccitech is associated with Vaccitech Team on 100Xfounder.

Where is Vaccitech located?

Vaccitech is listed in London, England, United Kingdom.

What stage is Vaccitech in?

Vaccitech is currently mapped to Ipo. Funding context: Sequoia, Post-IPO, $290M valuation

What is the latest funding round of Vaccitech?

Vaccitech's latest tracked round is IPO Sequoia, Post-IPO, $290M valuation. Total tracked rounds: 1.

Is Vaccitech hiring now?

Vaccitech hiring status: Open Roles.

What technologies does Vaccitech use?

Vaccitech is associated with Python, GCP, BigQuery, and React.

Is Vaccitech verified on 100Xfounder?

Yes. Vaccitech is currently marked verified on 100Xfounder as of April 17, 2026.

How can users connect with Vaccitech founders?

Users can open founder profiles, use listed company links, and track signal updates directly from the 100Xfounder directory.